No Data
No Data
Ceribell Insider Bought Shares Worth $4,032,978, According to a Recent SEC Filing
Express News | New Clinical Evidence Shows Ceribell Point-Of-Care EEG Reduces Hospital Stays And Improves Functional Outcomes Compared To Conventional EEG, Highlighted In Five Abstracts Presented At 2024 Neurocritical Care Society Annual Meeting
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Sector Update: Health Care
Top Midday Gainers
Express News | CeriBell IPO Shares Open For Trade At $23.26/Share; IPO Priced At $17/Share On 10.61M Shares
No Data
No Data